Evidence map›Paper›PMID 38880918›Full record

ArticleJournal of medical case reports2024

Hepatic myelopathy neurological complication of chronic liver disease: two case reports.

Mariem Mhiri, Mehdi Ben Abdelwahed, Mohamed Amine Dhiflaoui, Rihab Ben Dhia, Narjes Gouta, Imen Jemni, Raoua Baklouti, Mejda Zakhama, Arwa Gueddiche, Mohamed Hichem Loghmari and 3 more

Abstract readCase Reports
In one paragraph

Article in Journal of medical case reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Mariem MhiriDepartement of Neurology, CHU Fattouma Bourguiba, Fattouma Bourguiba Hospital, Avenue 1Er Juin. 5000, Monastir, Tunisia. mariemmhiri@yahoo.com.ORCID http://orcid.org/0000-0002-0802-4328
Mehdi Ben AbdelwahedDepartement of Gastro-Enterology, CHU Fattouma Bourguiba, Monastir, Tunisia.
Mohamed Amine DhiflaouiDepartement of Gastro-Enterology, CHU Fattouma Bourguiba, Monastir, Tunisia.
Rihab Ben DhiaDepartement of Neurology, CHU Fattouma Bourguiba, Fattouma Bourguiba Hospital, Avenue 1Er Juin. 5000, Monastir, Tunisia.
Narjes GoutaDepartement of Neurology, CHU Fattouma Bourguiba, Fattouma Bourguiba Hospital, Avenue 1Er Juin. 5000, Monastir, Tunisia.
Imen JemniDepartement of Gastro-Enterology, CHU Fattouma Bourguiba, Monastir, Tunisia.
Raoua BakloutiDepartement of Gastro-Enterology, CHU Fattouma Bourguiba, Monastir, Tunisia.
Mejda ZakhamaDepartement of Gastro-Enterology, CHU Fattouma Bourguiba, Monastir, Tunisia.
Arwa GueddicheDepartement of Gastro-Enterology, CHU Fattouma Bourguiba, Monastir, Tunisia.
Mohamed Hichem LoghmariDepartement of Gastro-Enterology, CHU Fattouma Bourguiba, Monastir, Tunisia.
Nabil Ben ChaabeneDepartement of Gastro-Enterology, CHU Fattouma Bourguiba, Monastir, Tunisia.
Leila SaferDepartement of Gastro-Enterology, CHU Fattouma Bourguiba, Monastir, Tunisia.
Mahbouba Frih-AyedDepartement of Neurology, CHU Fattouma Bourguiba, Fattouma Bourguiba Hospital, Avenue 1Er Juin. 5000, Monastir, Tunisia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundHepatic myelopathy is a very rare neurological complication of chronic liver disease. Patients habitually present with progressive pure motor spastic paraparesis. This neurological dysfunction is almost always due to cirrhosis and portocaval shunt, either surgical or spontaneous. CASES REPORT: We report two cases of a 57-year-old man and a 37-year-old woman with progressive spastic paraparesis linked to cirrhosis and portal hypertension. The two patients are of Tunisian origin (north Africa). Magnetic resonance imaging of the spinal cord of two patients was normal, while brain magnetic resonance imaging showed a T2 hypersignals of the pallidums. These signs, in favor of hepatic encephalopathy in the two patients with cirrhosis with isolated progressive spastic paraparesis without bladder or sensory disorders, help to retain the diagnosis of hepatic myelopathy.

conclusionHepatic myelopathy is a severe and debilitating neurological complication of chronic liver disease. The pathogenesis is misunderstood and seems to be multifactorial, including the selective neurotoxic role both of ammonia and other pathogenic neurotoxins. Usually a pathological brain magnetic resonance imaging showing a hepatic encephalopathy was documented, contrasting with a normal spinal cord magnetic resonance imaging that contributed to diagnosis of hepatic myelopathy. Conservative therapies such as ammonia-lowering measures, diet supplementation, antispastic drugs, and endovascular shunt occlusion show little benefit in improving disease symptoms. Liver transplantation performed at early stage can prevent disease progression and could probably allow for recovery.

Indexed as

Hepatic EncephalopathyLiver CirrhosisMagnetic Resonance ImagingSpinal Cord DiseasesAdultChronic DiseaseFemaleHumansHypertension, PortalMaleMiddle AgedParaparesis, SpasticHepatic myelopathyShuntSpastic paraparesis

Identifiers

PMID38880918
PMCPMC11181619

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.